EXPO
Exponent, Inc.
NASDAQ · Industrials · Consulting Services · US
$68.35
−2.43%Year over year
Reported trailing growth
- Revenue
- +12.8%
- EBITDA
- +1.1%
- EBIT
- +11.2%
- EPS
- +10.9%
- Free cash flow
- -10.2%
- Operating cash flow
- -8.6%
Forward estimates
Based on analyst estimates
- Revenue
- -3.3%
- EBITDA
- +10.1%
- EPS
- +9.2%
Three-year CAGR
- Revenue
- +4.3%
- EBITDA
- +4.1%
- EBIT
- -5.3%
- Net income
- +1.2%
- EPS
- +1.7%
- Free cash flow
- +14.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026